- Home
- AMRN vs WHF Comparison
AMRN vs WHF Comparison
Compare AMRN & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- WHF
- Stock Information
- Founded
- AMRN 1989
- WHF 2011
- Country
- AMRN Ireland
- WHF United States
- Employees
- AMRN N/A
- WHF N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- WHF Finance Companies
- Sector
- AMRN Health Care
- WHF Finance
- Exchange
- AMRN Nasdaq
- WHF Nasdaq
- Market Cap
- AMRN 216.0M
- WHF 212.0M
- IPO Year
- AMRN 1993
- WHF 2012
- Fundamental
- Price
- AMRN $16.19
- WHF $8.66
- Analyst Decision
- AMRN Strong Sell
- WHF Sell
- Analyst Count
- AMRN 1
- WHF 4
- Target Price
- AMRN $12.00
- WHF $10.83
- AVG Volume (30 Days)
- AMRN 166.2K
- WHF 102.2K
- Earning Date
- AMRN 07-30-2025
- WHF 08-07-2025
- Dividend Yield
- AMRN N/A
- WHF 20.64%
- EPS Growth
- AMRN N/A
- WHF N/A
- EPS
- AMRN N/A
- WHF 0.39
- Revenue
- AMRN $214,112,000.00
- WHF $86,143,000.00
- Revenue This Year
- AMRN N/A
- WHF N/A
- Revenue Next Year
- AMRN $7.88
- WHF N/A
- P/E Ratio
- AMRN N/A
- WHF $21.98
- Revenue Growth
- AMRN N/A
- WHF N/A
- 52 Week Low
- AMRN $7.08
- WHF $8.44
- 52 Week High
- AMRN $17.18
- WHF $12.73
- Technical
- Relative Strength Index (RSI)
- AMRN 76.95
- WHF 37.37
- Support Level
- AMRN $12.30
- WHF $9.18
- Resistance Level
- AMRN $17.18
- WHF $8.88
- Average True Range (ATR)
- AMRN 1.10
- WHF 0.17
- MACD
- AMRN 0.24
- WHF -0.04
- Stochastic Oscillator
- AMRN 82.10
- WHF 7.77
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.